Evidence map›Paper›PMID 42582267›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Benchmarking privacy and utility in synthetic tabular cohorts for Alzheimer's disease research.

Filip Winzell, Ida Arvidsson, Niels Christian Overgaard, Anders Heyden, Kalle Åström, Linda Karlsson, Jacob W Vogel, Oskar Hansson, Niklas Mattsson-Carlgren, Alzheimer's Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Filip WinzellCentre for Mathematical Sciences Lund University Lund Sweden.
Ida ArvidssonCentre for Mathematical Sciences Lund University Lund Sweden.
Niels Christian OvergaardCentre for Mathematical Sciences Lund University Lund Sweden.
Anders HeydenCentre for Mathematical Sciences Lund University Lund Sweden.
Kalle ÅströmCentre for Mathematical Sciences Lund University Lund Sweden.
Linda KarlssonClinical Memory Research Unit Department of Clinical Sciences in Malmö Lund University Lund Sweden.
Jacob W VogelDepartment of Clinical Sciences Malmö, SciLifeLab Lund University Lund Sweden.
Oskar HanssonWallenberg Center for Molecular Medicine Lund University Lund Sweden.
Niklas Mattsson-CarlgrenDepartment of Clinical Sciences Malmö, SciLifeLab Lund University Lund Sweden.
Alzheimer's Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Prospective validation and implementation of high-performing blood biomarkers and digital cognitive tests for detection of Alzheimer's disease in specialist memory clinic and primary care settingsR01AG083740 · NIA · LUNDS UNIVERSITET · PI Sebastian Palmqvist · 2023 to 2026
$1.9M
NIA NIH HHS R01 AG083740NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

introductionThe scarcity of large, clinically relevant cohorts is becoming a bottleneck in Alzheimer's disease (AD) research, as their sensitive nature makes open data sharing difficult. Privacy-preserving synthetic datasets generated with machine learning may help address this challenge.

methodsWe compared five frameworks for generating synthetic tabular data from the Alzheimer's Disease Neuroimaging Initiative and Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease cohorts, with a set of empirical privacy and utility metrics. Two of the methods, DataSynthesizer and TableDiffusion, provide

resultsMethods with differential privacy achieved high privacy ratings but low levels of utility. Deep learning methods like Tabular Prior-data Fitted Network (TabPFN) and Conditional Generative Adversarial Network (CTGAN) also showed high privacy with limited utility. In contrast, non-private DataSynthesizer and Synthpop offered higher utility at a cost of lower privacy. DISCUSSION: The evaluated methods demonstrated a clear trade-off between privacy and utility. High privacy was generally associated with insufficient utility, highlighting the need for further research into synthetic data generation for AD.

Indexed as

Alzheimer's diseasemachine learningsynthetic datatabular data

Identifiers

PMID42582267
PMCPMC13457355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.